A new report has thrown light on the difficulty suffered by deaf and blind people in procuring medicines and medical devices. Experts warned against major deficiencies in...
Taiwan is engaged in an effort to collaborate with India to boost its competitive position in the global life sciences market and counter the...
Novartis, a global healthcare company, and Docquity, Southeast Asia's largest network of healthcare professionals (HCPs), have revealed a multi-year collaboration in Malaysia to tackle the increase in retinal health challenges such as age-related....
According to new research from the University of Bath, people with dementia can lead productive working lives in the digital age, dispelling the myth that dementia is...
A research collaboration agreement has been signed between Panchkula-based Venus Remedies Limited and AdjuTec Pharma AS, a Norwegian firm that is creating antibiotic resistance breakers. AdjuTec Pharma's APC-148 platform technology will undergo....
Eli Lilly, a major global pharmaceutical firm, recently launched its breakthrough anti-obesity medicine Mounjaro (tirzepatide) and strategies to increase production of insulin...
With a strategic focus on positioning India as a global R&D center in pharmaceutical and medical technology, the Government’s launch of the Expression of Interest (EOI) focuses on promoting research and innovation in the Pharma MedTech Sector (PRIP)
Researchers at the University of Queensland are developing nanotechnology that will improve treatment for the most aggressive form of breast cancer. Professor Chengzhong (Michael) Yu and his colleagues are developing new nanoparticles to enhance...
India is taking a significant step in cardiac treatment by enhancing left ventricular assist devices (LVADs), which can aid the heart in pumping blood, which results in patients experiencing end-stage heart failure as they wait for a heart donor. A g
In a tactical initiative to improve drug safety oversight, Tech Mahindra, a worldwide frontrunner in technology consulting and digital services, has revealed an AI-based pharmacovigilance (PV) solution utilizing NVIDIA AI software. The solution seeks
, CDSCO.jpg)
